Is taking glutathione better than taking NAC, and do oral, liposomal and intravenous forms produce different results?

NAC supplies a building block for glutathione production, while glutathione products deliver the molecule itself. Neither approach is universally “better.” A six-month placebo-controlled trial found that oral glutathione could increase body glutathione stores, so the claim that oral glutathione can never be absorbed or have an effect is too absolute. A small liposomal pilot also reported increased glutathione measures, but it lacked a placebo comparison. These studies mainly address biochemical measures, not whether people become less fatigued, live longer or recover faster.[1][2]

Liposomal formulations aim to change delivery, while intravenous administration bypasses the gut. Neither feature proves superior clinical benefit or makes evidence from one product transferable to all others. A useful comparison would test the actual formulations head-to-head on symptoms or disease outcomes. Intravenous treatment also introduces preparation and administration risks: FDA alerts have documented excessive endotoxin in compounded glutathione injections, including renewed concerns in 2026. Paying for a drip or achieving a larger blood-level change is not evidence of a better health outcome.[2][3]